ROSIGLITAZONE SHOWS SEQUENCE-SPECIFIC SYNERGY WITH CHEMOTHERAPEUTIC DRUGS IN INHIBITION OF MCF-7 BREAST CANCER CELL LINE

Sally Al-Moualem, Fawza Monem

Open source

DOI
10.21608/bfsa.2021.174137
Published
2021-06-01
Container
Bulletin of Pharmaceutical Sciences. Assiut
Publisher
Egypts Presidential Specialized Council for Education and Scientific Research
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21608/bfsa.2021.174137,
  title = {ROSIGLITAZONE SHOWS SEQUENCE-SPECIFIC SYNERGY WITH CHEMOTHERAPEUTIC DRUGS IN INHIBITION OF MCF-7 BREAST CANCER CELL LINE},
  author = {Sally Al-Moualem and Fawza Monem},
  year = {2021},
  journal = {Bulletin of Pharmaceutical Sciences. Assiut},
  doi = {10.21608/bfsa.2021.174137},
  url = {https://doi.org/10.21608/bfsa.2021.174137}
}

RIS

TY  - JOUR
TI  - ROSIGLITAZONE SHOWS SEQUENCE-SPECIFIC SYNERGY WITH CHEMOTHERAPEUTIC DRUGS IN INHIBITION OF MCF-7 BREAST CANCER CELL LINE
AU  - Sally Al-Moualem
AU  - Fawza Monem
PY  - 2021
JO  - Bulletin of Pharmaceutical Sciences. Assiut
DO  - 10.21608/bfsa.2021.174137
UR  - https://doi.org/10.21608/bfsa.2021.174137
ER  - 

APA

Al-Moualem, S., & Monem, F. (2021). ROSIGLITAZONE SHOWS SEQUENCE-SPECIFIC SYNERGY WITH CHEMOTHERAPEUTIC DRUGS IN INHIBITION OF MCF-7 BREAST CANCER CELL LINE. Bulletin of Pharmaceutical Sciences. Assiut. https://doi.org/10.21608/bfsa.2021.174137

Source records